These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
257 related items for PubMed ID: 14872504
1. Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial. Rubin BR, Burton R, Navarra S, Antigua J, Londoño J, Pryhuber KG, Lund M, Chen E, Najarian DK, Petruschke RA, Ozturk ZE, Geba GP. Arthritis Rheum; 2004 Feb; 50(2):598-606. PubMed ID: 14872504 [Abstract] [Full Text] [Related]
2. Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis. Schumacher HR, Boice JA, Daikh DI, Mukhopadhyay S, Malmstrom K, Ng J, Tate GA, Molina J. BMJ; 2002 Jun 22; 324(7352):1488-92. PubMed ID: 12077033 [Abstract] [Full Text] [Related]
3. Etoricoxib versus indometacin in the treatment of Chinese patients with acute gouty arthritis: a randomized double-blind trial. Li T, Chen SL, Dai Q, Han XH, Li ZG, Wu DH, Zhang X, Gu JR, Yang NP, Sun LY, Zhang MJ, Li XF, Bao CD. Chin Med J (Engl); 2013 Jun 22; 126(10):1867-71. PubMed ID: 23673101 [Abstract] [Full Text] [Related]
4. Association of baseline disease and patient characteristics with response to etoricoxib and indomethacin for acute gout. Navarra S, Rubin BR, Yu Q, Smugar SS, Tershakovec AM. Curr Med Res Opin; 2007 Jul 22; 23(7):1685-91. PubMed ID: 17588299 [Abstract] [Full Text] [Related]
5. Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout. Willburger RE, Mysler E, Derbot J, Jung T, Thurston H, Kreiss A, Litschig S, Krammer G, Tate GA. Rheumatology (Oxford); 2007 Jul 22; 46(7):1126-32. PubMed ID: 17478464 [Abstract] [Full Text] [Related]
6. Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study. van der Heijde D, Baraf HS, Ramos-Remus C, Calin A, Weaver AL, Schiff M, James M, Markind JE, Reicin AS, Melian A, Dougados M. Arthritis Rheum; 2005 Apr 22; 52(4):1205-15. PubMed ID: 15818702 [Abstract] [Full Text] [Related]
7. Efficacy and tolerability profile of etoricoxib in patients with osteoarthritis: A randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial. Leung AT, Malmstrom K, Gallacher AE, Sarembock B, Poor G, Beaulieu A, Castro R, Sanchez M, Detora LM, Ng J. Curr Med Res Opin; 2002 Apr 22; 18(2):49-58. PubMed ID: 12017209 [Abstract] [Full Text] [Related]
8. Efficacy and safety of etoricoxib compared with NSAIDs in acute gout: a systematic review and a meta-analysis. Zhang S, Zhang Y, Liu P, Zhang W, Ma JL, Wang J. Clin Rheumatol; 2016 Jan 22; 35(1):151-8. PubMed ID: 26099603 [Abstract] [Full Text] [Related]
9. Comparison of Prednisolone, Etoricoxib, and Indomethacin in Treatment of Acute Gouty Arthritis: An Open-Label, Randomized, Controlled Trial. Xu L, Liu S, Guan M, Xue Y. Med Sci Monit; 2016 Mar 11; 22():810-7. PubMed ID: 26965791 [Abstract] [Full Text] [Related]
10. Evaluation of multiday analgesia with etoricoxib in a double-blind, randomized controlled trial using the postoperative third-molar extraction dental pain model. Brown JD, Daniels SE, Bandy DP, Ko AT, Gammaitoni A, Mehta A, Boice JA, Losada MC, Peloso PM. Clin J Pain; 2013 Jun 11; 29(6):492-8. PubMed ID: 23247002 [Abstract] [Full Text] [Related]
12. Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4-week, multinational, randomized, double-blind study. Zerbini C, Ozturk ZE, Grifka J, Maini M, Nilganuwong S, Morales R, Hupli M, Shivaprakash M, Giezek H, Etoricoxib CLBP Study Group. Curr Med Res Opin; 2005 Dec 11; 21(12):2037-49. PubMed ID: 16368055 [Abstract] [Full Text] [Related]
13. Etoricoxib in the treatment of primary dysmenorrhea in Chinese patients: a randomized controlled trial. Yu Q, Zhu X, Zhang X, Zhang Y, Li X, Hua Q, Chang Q, Zou Q, Di W, Yao Y, Yu W, Liu J, Mehta A, Yan L. Curr Med Res Opin; 2014 Sep 11; 30(9):1863-70. PubMed ID: 24960147 [Abstract] [Full Text] [Related]
14. A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis. Zacher J, Feldman D, Gerli R, Scott D, Hou SM, Uebelhart D, Rodger IW, Ozturk ZE, etoricoxib OA study group. Curr Med Res Opin; 2003 Sep 11; 19(8):725-36. PubMed ID: 14687444 [Abstract] [Full Text] [Related]
15. A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis. Balazcs E, Sieper J, Bickham K, Mehta A, Frontera N, Stryszak P, Popmihajlov Z, Peloso PM. BMC Musculoskelet Disord; 2016 Oct 13; 17(1):426. PubMed ID: 27737664 [Abstract] [Full Text] [Related]
18. Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial. Pallay RM, Seger W, Adler JL, Ettlinger RE, Quaidoo EA, Lipetz R, O'Brien K, Mucciola L, Skalky CS, Petruschke RA, Bohidar NR, Geba GP. Scand J Rheumatol; 2004 Oct 13; 33(4):257-66. PubMed ID: 15370723 [Abstract] [Full Text] [Related]
19. Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator. Terkeltaub RA, Schumacher HR, Carter JD, Baraf HS, Evans RR, Wang J, King-Davis S, Weinstein SP. Arthritis Res Ther; 2013 Feb 01; 15(1):R25. PubMed ID: 23375025 [Abstract] [Full Text] [Related]
20. A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis. Matsumoto AK, Melian A, Mandel DR, McIlwain HH, Borenstein D, Zhao PL, Lines CR, Gertz BJ, Curtis S, Etoricoxib Rheumatoid Arthritis Study Group. J Rheumatol; 2002 Aug 01; 29(8):1623-30. PubMed ID: 12180720 [Abstract] [Full Text] [Related] Page: [Next] [New Search]